Tinzaparin for the prevention of thromboembolic events in ambulatory patients with metastatic colorectal cancer receiving first line treatment: a randomised, clinical trial design. - Salgado M; de la Camara-Gómez J; García-Escobar I; Álvarez-Llosa RC; González-Villarroel P; Garay DF; Pàmpols-Felip M; Guillot-Morales M; Pelegrín-Mateo FJ; Jimenez-Orozco E; Sastre J; de Castro EM; et al. (BMC cancer, 2025)